Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole for Breast Cancer Prevention in BRCA1/BRCA2 Carriers
NCT00673335Phase 3Completed
- Sponsor
- Unicancer
- Start
- May 2008
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of letrozole in breast cancer, sponsored by Unicancer. Started May 2008; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00673335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00673335.